Host and virological characteristics of patients with hepatitis C virus mixed genotype 1 and 2 infection

被引:4
|
作者
Huang, Chung-Feng [1 ,2 ]
Huang, Ching-I [1 ,3 ]
Yeh, Ming-Lun [3 ]
Huang, Jee-Fu [3 ,4 ]
Hsieh, Ming-Yen [3 ]
Lin, Zu-Yau [3 ,4 ]
Chen, Shinn-Cherng [3 ,4 ]
Yu, Ming-Lung [3 ,4 ]
Dai, Chia-Yen [3 ,4 ,5 ,6 ]
Chuang, Wan-Long [3 ,4 ]
机构
[1] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Occupat Med, Kaohsiung, Taiwan
[3] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ, Coll Med, Fac Internal Med, Sch Med, Kaohsiung, Taiwan
[5] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Occupat Med, Kaohsiung, Taiwan
[6] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Prevent Med, Kaohsiung, Taiwan
关键词
Genotype; Hepatitis C virus; Interleukin-28B; Mixed infection; INTERLEUKIN-28B GENETIC-VARIANTS; HEPATOCELLULAR-CARCINOMA; RIBAVIRIN THERAPY; VIRAL-HEPATITIS; HCV; INTERFERON; IL28B; SUPERINFECTION; POLYMORPHISMS; ASSOCIATION;
D O I
10.1016/j.kjms.2015.02.004
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The prevalence and characteristics of patients with hepatitis C virus mixed genotype 1 and 2 infection (HCV-1/ 2) remains unclear. For each HCV-1/ 2 patient with histological data available, two age-and sex-matched HCV-1 and HCV-2 infected patients were selected for comparison, respectively. Of the 2776 patients, 261 (9.4%) patients were identified as having mixed HCV-1/ 2 infection. The histological severity did not differ among HCV-1/ 2 patients and controls. The proportion of patients with the interleukin-28B (IL-28B) rs8099917 TT genotype did not differ between patients with mixed-1/ 2 and HCV-1 infection (82.6% vs. 86.5%, p = 0.38). However, HCV-2 infected patients had a significantly higher proportion of the rs8099917 TT genotype compared to patients with mixed HCV-1/ 2 infections (91.6% vs. 82.6%, p = 0.03). The HCV RNA levels were similar in patients with HCV-1/ 2 and HCV-1 infections (5.5 +/- 0.8 log IU/mL vs. 5.5 +/- 0.9 log IU/L, p = 0.73), which were both significantly higher than that of HCV-2 infection (5.1 +/- 0.9 log IU/mL, both p < 0.001). Linear regression analysis revealed that the factors of HCV-1/2 infection [beta: 0.204; 95% confidence interval (CI): 0.183-0.598, p < 0.001], bodyweight(beta:0.150;CI: 0.003-0.021, p = 0.008), and age (beta: - 0.139; CI: - 0.020 to - 0.002, p = 0.01) were independently correlated with HCV RNA levels in patients with HCV-2 and mixed HCV-1/2 infection. We concluded that the host genetic and viral presentations of patients with mixed HCV-1/2 infection were more similar to those of patients with HCV-1 infection than patients with HCV-2 infection. Copyright (C) 2015, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights reserved.
引用
收藏
页码:271 / 277
页数:7
相关论文
共 50 条
  • [1] Hepatitis C virus mixed genotype infection in patients on haemodialysis
    Qian, KP
    Natov, SN
    Pereira, BJG
    Lau, JYN
    JOURNAL OF VIRAL HEPATITIS, 2000, 7 (02) : 153 - 160
  • [2] Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapse
    Lagging, Martin
    Rembeck, Karolina
    Buhl, Mads Rauning
    Christensen, Peer
    Dalgard, Olav
    Farkkila, Martti
    Hellstrand, Kristoffer
    Langeland, Nina
    Lindh, Magnus
    Westin, Johan
    Norkrans, Gunnar
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2013, 48 (07) : 839 - 847
  • [3] Peginterferon alpha-2b plus ribavirin for chronic hepatitis C virus mixed genotype infection
    Lin, Ching-Chung
    Wu, Chia-Hsien
    Chen, Huan-Lin
    Lin, I-Tsung
    Wang, Shen-Yung
    Wang, Tsang-En
    Wang, Horng-Yuan
    Shih, Shou-Chuan
    Bair, Ming-Jong
    ANNALS OF HEPATOLOGY, 2014, 13 (04) : 350 - 355
  • [4] Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients
    Anggorowati, Nungki
    Yano, Yoshihiko
    Heriyanto, Didik Setyo
    Rinonce, Hanggoro Tri
    Utsumi, Takako
    Mulya, Deshinta Putri
    Subronto, Yanri Wijayanti
    Hayashi, Yoshitake
    JOURNAL OF MEDICAL VIROLOGY, 2012, 84 (06) : 857 - 865
  • [5] Predictors of sustained virological response in patients with hepatitis C virus genotype 3 infection
    Zarebska-Michaluk, Dorota
    Lebensztejn, Dariusz
    Chrapek, Magdalena
    Paluch, Katarzyna
    Stepien, Piotr
    Kryczka, Wieslaw
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2016, 2 (03) : 117 - 124
  • [6] Treatment efficacy of pegylated interferon plus ribavirin therapy in chronic hepatitis C patients with mixed genotype 1/2 infection
    Huang, Ching-I
    Huang, Chung-Feng
    Huang, Jee-Fu
    Dai, Chia-Yen
    Yeh, Ming-Lun
    Hsieh, Ming-Yen
    Lin, Zu-Yau
    Chen, Shinn-Cherng
    Wang, Liang-Yen
    Yu, Ming-Lung
    Chuang, Wan-Long
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (05) : 1012 - 1018
  • [7] Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study
    Tada, Toshifumi
    Kumada, Takashi
    Okushin, Hiroaki
    Tani, Joji
    Takaguchi, Koichi
    Tsutsui, Akemi
    Toyoda, Hidenori
    Yasuda, Satoshi
    Dohmen, Kazufumi
    Hiraoka, Atsushi
    Michitaka, Kojiro
    Nouso, Kazuhiro
    Kariyama, Kazuya
    Kim, Soo Ryang
    Kim, Soo Ki
    Fujioka, Shinichi
    Mikami, Shigeru
    Watanabe, Yuto
    Tamai, Tsutomu
    Atsukawa, Masanori
    Itokawa, Norio
    Tanaka, Hironori
    Tsuji, Kunihiko
    Ishikawa, Toru
    Imai, Michitaka
    Itobayashi, Ei
    Shibata, Hiroshi
    Shimada, Noritomo
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (01) : 269 - 280
  • [8] Efficacy of Sofosbuvir Plus Ribavirin With or Without Peginterferon-Alfa in Patients With Hepatitis C Virus Genotype 3 Infection and Treatment-Experienced Patients With Cirrhosis and Hepatitis C Virus Genotype 2 Infection
    Foster, Graham R.
    Pianko, Stephen
    Brown, Ashley
    Forton, Daniel
    Nahass, Ronald G.
    George, Jacob
    Barnes, Eleanor
    Brainard, Diana M.
    Massetto, Benedetta
    Lin, Ming
    Han, Bin
    McHutchison, John G.
    Subramanian, G. Mani
    Cooper, Curtis
    Agarwal, Kosh
    GASTROENTEROLOGY, 2015, 149 (06) : 1462 - 1470
  • [9] Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan
    Toyoda, Hidenori
    Atsukawa, Masanori
    Takaguchi, Koichi
    Senoh, Tomonori
    Michitaka, Kojiro
    Hiraoka, Atsushi
    Fujioka, Shinichi
    Kondo, Chisa
    Okubo, Tomomi
    Uojima, Haruki
    Tada, Toshifumi
    Yoneyama, Hirohito
    Watanabe, Tsunamasa
    Asano, Toru
    Ishikawa, Toru
    Tamai, Hideyuki
    Abe, Hiroshi
    Kato, Keizo
    Tsuji, Kunihiko
    Ogawa, Chikara
    Shimada, Noritomo
    Iio, Etsuko
    Deguchi, Akihiro
    Itobayashi, Ei
    Mikami, Shigeru
    Moriya, Akio
    Okubo, Hironao
    Tani, Joji
    Tsubota, Akihito
    Tanaka, Yasuhito
    Masaki, Tsutomu
    Iwakiri, Katsuhiko
    Kumada, Takashi
    JOURNAL OF GASTROENTEROLOGY, 2018, 53 (12) : 1276 - 1284
  • [10] Cryoglobulinemia in Japanese patients with chronic hepatitis C virus infection: Host genetic and virological study
    Nagasaka, A
    Takahashi, T
    Sasaki, T
    Takimoto, K
    Miyashita, K
    Nakamura, M
    Wakahama, O
    Nishikawa, S
    Higuchi, A
    JOURNAL OF MEDICAL VIROLOGY, 2001, 65 (01) : 52 - 57